Sculptra side effects are an essential consideration for any practitioner using this biostimulatory filler. Sculptra®, with poly-L-lactic acid (PLLA) as its active ingredient, is an injectable treatment approved by the FDA in 2004. Initially used for facial lipoatrophy in HIV patients, it has become widely adopted in aesthetic medicine for facial volume restoration and dermal regeneration. Unlike traditional hyaluronic acid fillers, Sculptra works by stimulating neocollagenesis, offering...








